Drug Absorption Flashcards

1
Q

drug absorption

A

absorption is the movement of a drug from its site of administrateion int o the central compartment of systemic circulation

achieves adequate plasma concentration at its site of action in order to produce its pharmacological effects

amount of absorption depends on routes of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

bioavailability

A

the fractional extent to which an administered drug reaches systemic circulation

the main criterion for choosing the route of administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

routes of administration

A

intravenous

transdermal

subcutaneous

intramuscular

inhalational

sublingual and buccal

oral

rectal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

oral administration and the stages before therapeutic effect

A

most common because it is safest, most convenient, and most economical

phases - pharmaceutical, pharmacokinetic, pharmacodynamic, effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pharmaceutical phase

A

disintegration of dosage form, dissolution of active ingredients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharmacokinetic phase

A

absorption, distribution, metabolism, excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pharmacodynamic phase

A

drug-receptor interaction, drug-drug interaction, individual sensitivity, pathophysiological conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

physiological parameters of human small intestines

A

gastric pH is 1.5 to 2.5

duodenum from 5 to 6

jejunum to ileum is 6 to 7 to 7.5

effective surface area 71-250m^2

gastric surface area 155cm^2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

direct interactions that affect drug absorption

A

physiological factors:

gastric emptying time is slowed by foods

drugs may be destroyed by the gastric pH or digestive enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

didanosine intake

A

anti-HIV drug

most effective when taken 0.5-1 hour before or 2 horus after meals

acid-sensitive drug, prolonged gastric time will cause degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

nitrofurantoin intake

A

better taken with food because the drug is not very soluble and increased dissolution time in the intestine helps absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

first pass effect

A

drugs may be metabolized in the gut and subsequently in the liver before gaining access to the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

major drug metabolizing enzyme int he gut

A

P450 (CYP3A4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

grapefruit jiuce and drug interactions

A

grapefruit juice could alter drug concentrations via two mechanisms:

inhibiting CYP3A4 drug metabolizing in the gut - irreversible (96 hours to replenish)

inhibiting uptake transporter OATPs - reversible (after 4 hours)

found to enhance antihypertensive effects of felodipine because metabolizing enzymes were inhibited

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

controlled-release formulations

A

preparations of drugs designed to produce slow, uniform absorption for 8 or more hours, achieving a stable blood concentration

eliminates extreme peaks and troughs of blood drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

disadvantages of oral administration

A

first-pass effect and destruction of drug

onset of effect is too slow for emergencies

not able to administrate to unconscious patients or when vomiting is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

rectal administration

A

alternative to oral when the patient is unconscious or when ovmiting

used to treat local conditions such as hemorrhoids

dosage may include solutions or suppositories

rectal absorption can be erratic

lowered potential for hepatic first-pass metabolism

50% bypasses the liver

18
Q

parenteral routes of drug delivery

A

interavenous, intramuscular, subcutaneous

19
Q

intravenous injection

A

100% bioavailability, bypass first-pass effects

results in potentially immediate effect, good for emergencies

permits titration of dose

suitable for large volumes, but may have adverse effects because of rapidly attained high concentrations

once the drug is injected, there is no retreat

20
Q

intramuscular injection

A

absorption of lipids through diffusion along concentration gradients

absportion of lipid-insoluble drugs goes through interendothelial loose junctions, macula occludens with pore size of 4-5 nm, or transcytosis

absorption may be made slow and sustained by using repository preparations

suitable for moderate volumes, oily vehicles, and some irritating drugs

may be pain at site of injection

21
Q

subcutaneous injection

A

similar to intramuscular injection

suitable for some water-insoluble suspensions and for implantation of solid pellets

not suitable for large volumes or irritating substances

concurrent administration of vasoconstrivtor will slow abosrption

22
Q

intrathecal injections

A

enhances the entrance of drugs into CNS, circumvents blood-brain barrier and blood-CSF barrier

uses extremely permeable ependymal cells lining ventricles

can be used to treat acute CNS infections with antibiotics

23
Q

inhalation

A

gaseous and volatile agents and aerosols are absorbed rapidly via lungs because of large surface area of alveoli, which is perfused by high blood flow

thin membranes separate alveoli from circulation

inhalation of volatile general anesthesia

24
Q

topical application

A

through skin or transdermal mucous membranes

skin is a pipoidal membrane barrier, so only highly lipid soluble drugs are absorbed

absorption is faster through mucous membrane than through skin

drugs can be administered sublingually or by dermal patch, avoid first-pass effect

25
Q

three criteria of generic drugs

A

pharmaceutical equivalent

bioequivalent

effective and safe

26
Q

pharmaceutical equivalents

A

same active ingredients

identical in strength or concentration

same dosage form

same route of administration

27
Q

bioequivalence

A

when two pharmaceutical equivalent drugs produce the same rates and extents of bioavailability of the same active ingredient, they are considered to be bioequivalent

28
Q

reasons why pharmaceutical equivalence does not equal bioequivalence

A

may have differences in crystal form, particle size, and manufacturing processes

29
Q

criteria for FDA to approve a generic drug

A

pharmaceutical equivalence

bioequivalence (80% to 125% of bioequivalence to the brand name drug)

safety and effectiveness for intended use

30
Q

drug distribution

A

after absorption, a drug distributes to interstitial and intracellular fluids

process influenced by a number of physiological factors and the particular physicochemical properties of the individual drug

31
Q

first phase of tissue distribution

A

rapid distribution to organs of high blood flow: brain, heart, liver, and kidneys

32
Q

second phase of tissue distribution

A

drug delivery to muscle, most viscera, skin, and fat which have moderate blood flow

33
Q

final tissue distribution

A

depends on the properties of the drug and its affinity for the tissue site

lipid soluble, nonionized drugs are readily distributed to all tissues, especially adipose tissue

ionized drugs in generall will remain in the plasma and intersitial compartments

34
Q

anitomical properties of the blood-brain barrier

A

lacks fenestration and vesicles in endothelial cells

tight junctions

limited extracellular spaces, covered by basal membrane, astrocyte end-foot processes and pericytes

35
Q

biochemical properties of the blood-brain barrier

A

ABC transporters on luminal surfaces of endothelial cells that pushes drugs back into the blood

36
Q

entry of drugs into the CNS

A

permeable to lipid-soluble drugs - entry of drug is proportional to its lipid solubility and concentration gradient

if both ionized and non-ionized forms exist, entry is proportional to the non-ionized form

37
Q

blood-cerebrospinal fluid barrier

A

resides in the epithelial cells of the choroid plexu, which have tight junctions

only lipid-soluble drugs get into the CSF from the blood

not as significant as the blood-brain barrier

ependymal cells lining ventricles are not connected by tight junctions an doffer unrestricted passage of drug molecules between CSF and brain cells

38
Q

pharmacologically inactive

A

describes a drug bound to a protein such as albumin and can no longer confer function

plasma proteins may be storage to prolong drug action

39
Q

localized distribution

A

uptake transporters and enterohepatic recirculation of drugs have been shown to achieve liver-specific distribution of statins, which enhance the therapeutic action of stains in the liver to reduce cholesterol synthesis and reduce the systemic drug level preventing myotoxicity

40
Q

phenytoin

A

narrow therapeutic index

hard to control because serum levels increase exponentially depending on albumin binding and other factors

41
Q

when are drug-drug interactions not of a concern

A

if the drug has high therapeutic index

if the drug response is slow